T2 Biosystems Inc EBITDA
What is the EBITDA of T2 Biosystems Inc?
The EBITDA of T2 Biosystems Inc is -$42.13
What is the definition of EBITDA?
EBITDA is a company’s earnings before interest, taxes, depreciation, and amortization and is an accounting measure calculated using a company’s net earnings, before interest expenses, taxes, depreciation and amortization are subtracted, as a proxy for a company’s current operating profitability.
ttm (trailing twelve months)
Although EBITDA is not a financial measure recognized in generally accepted accounting principles, it is widely used in many areas of finance when assessing the performance of a company, such as securities analysis. It is intended to allow a comparison of profitability between different companies, by discounting the effects of interest payments from different forms of financing (by ignoring interest payments), political jurisdictions (by ignoring tax), collections of assets (by ignoring depreciation of assets), and different takeover histories (by ignoring amortization often stemming from goodwill). EBITDA is a financial measurement of cash flow from operations that is widely used in mergers and acquisitions of small businesses and businesses in the middle market. It is not unusual for adjustments to be made to EBITDA to normalize the measurement allowing buyers to compare the performance of one business to another.
EBITDA of companies in the Health Care sector on NASDAQ compared to T2 Biosystems Inc
What does T2 Biosystems Inc do?
t2 biosystems is developing innovative diagnostic products to improve patient health. with two fda-cleared products targeting sepsis – the cause of one out of two hospital deaths - and a range of additional products in development, t2 biosystems is an emerging leader in the field of in vitro diagnostics. our initial development efforts target sepsis, hemostasis, bacteria and lyme disease, which are areas of significant unmet medical need. the company is utilizing its proprietary t2 magnetic resonance platform, or t2mr®, to develop a broad set of applications aimed at lowering mortality rates, improving patient outcomes and reducing the cost of healthcare by helping medical professionals make targeted treatment decisions earlier. at t2 biosystems, we know that our passion to advance the medical diagnostic landscape relies on our ability to attract and retain the very best people in the world – and to encourage them to flourish. we invite you to apply for one of our open positions at www
Companies with ebitda similar to T2 Biosystems Inc
- Elmo Software has EBITDA of -AUD$42.33
- Elmo Software has EBITDA of -AUD$42.33
- CyberArk Software Ltd has EBITDA of -$42.29
- Modern Healthcare Technology has EBITDA of -HKD$42.23
- PAVmed has EBITDA of -$42.20
- China Bozza Development has EBITDA of -¥42.15
- T2 Biosystems Inc has EBITDA of -$42.13
- Cardiol Therapeutics has EBITDA of -CAD$42.12
- China Silver has EBITDA of -¥41.98
- Culturecom has EBITDA of -HKD$41.93
- 3D Systems has EBITDA of -$41.72
- 3D Systems has EBITDA of -$41.72
- Sterling has EBITDA of -HKD$41.72